|
"BCR/ABL-PI-3k-ROS pathway induce genomic instability ...."
|
5R01CA134458-03
|
$307,951
|
$307,951
|
SKORSKI, TOMASZ
|
TEMPLE UNIVERSITY
|
|
"Oncorequisite" Genes in MYC-mediated Transformation
|
4R00CA134743-03
|
$233,147
|
$186,518
|
FENG, HUI
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
24th Annual Fanconi Anemia Research Fund Scientific Symposium
|
1R13CA171695-01
|
$1
|
$1
|
Bagby, Grover
|
FANCONI ANEMIA RESEARCH FUND, INC.
|
|
5-hydroxymethylcytosine in human cancer
|
1R01CA160965-01A1
|
$348,600
|
$174,300
|
Pfeifer, Gerd
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
???Novel melampomagnolide B-based prodrugs for the treatment of leukemia???
|
5R01CA158275-03
|
$313,325
|
$313,325
|
Crooks, Peter
|
UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120-02060
|
$354,811
|
$141,924
|
Rothman, Nat
|
DCEG (NCI)
|
|
A CROSS-SECTIONAL STUDY OF OCCUPATIONAL EXPOSURE TO TRICHLOROETHYLENE, CHROMOSOMAL ABERRATIONS, AND
|
ZIA CP010121-10363
|
$35,570
|
$35,570
|
Lan, Qing
|
DCEG (NCI)
|
|
A Flexible and Concise Approach to the Citrinadins: Total Synthesis of Citrinadin
|
1F32CA167908-01
|
$47,114
|
$23,557
|
Mundal, Devon
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
A Novel Modulator of Notch in Acute Lymphoblastic Leukemia
|
5R21CA161436-02
|
$176,175
|
$176,175
|
Liang, Chengyu
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
A Novel sequencing-based approach to discovering rare genetic factors for ALL.
|
5K08CA140720-03
|
$149,387
|
$149,387
|
Druley, Todd
|
WASHINGTON UNIVERSITY
|
|
A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials
|
2R44CA144362-02A1
|
$689,294
|
$172,324
|
Wiener, Matthew
|
PHARMATECH, INC.
|
|
A Phase II proof-of-concept trial to study kinase inhibition in relapsed/refracto
|
5R21CA159265-02
|
$272,667
|
$272,667
|
LORIAUX, MARC
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
|
A Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL
|
5R21CA161688-02
|
$321,931
|
$321,931
|
Burke, Michael
|
UNIVERSITY OF MINNESOTA
|
|
A role for elevated autophagy in survival and chemoresistance of leukemia stem ce
|
1R21CA158728-01A1
|
$220,545
|
$220,545
|
Guzman, Monica
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIASC010356
|
$343,957
|
$34,396
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
5R01CA055577-19
|
$256,139
|
$204,911
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A Universal Approach to Personalized Adoptive T cell Therapy of Cancer
|
1R01CA168900-01
|
$332,000
|
$166,000
|
Powell, Daniel
|
UNIVERSITY OF PENNSYLVANIA
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,258,475
|
$62,924
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Aberrant activation of HGF/MET signaling as a therapeutic target in AML
|
5K08CA160660-02
|
$156,330
|
$156,330
|
Kentsis, Alex
|
DANA-FARBER CANCER INSTITUTE
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-36
|
$7,725,062
|
$463,504
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIASC010378
|
$441,016
|
$220,508
|
Aplan, Peter
|
CCR (NCI)
|
|
Adoptive Immunotherapy of Cancer with IL-12 Secreting Tumor-Targeted T cells
|
5R01CA138738-04
|
$381,617
|
$190,809
|
Brentjens, Renier
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Adult Leukemia Research Center
|
2P01CA018029-37A1
|
$4,225,448
|
$3,422,613
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Agricultural Health Study - Biomarkers of Exposures and Effects in Agriculture
|
ZIA CP010119-10527
|
$441,719
|
$220,860
|
Alavanja, Michael
|
DCEG (NCI)
|
|
AID-mediated genetic instability in BCR-ABL1-transformed B cell lineage leukemia
|
5R01CA139032-04
|
$322,040
|
$322,040
|
Muschen, Markus
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
ALL therapy and developing brains: MRI measures, genetic factors and cognition
|
5R01CA090246-07
|
$380,224
|
$380,224
|
REDDICK, WILBURN
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Allogeneic stem cell transplant with grafts depleted of naive T cells for leukemi
|
5K23CA154532-02
|
$170,100
|
$170,100
|
Bleakley, Marie
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIABC011415
|
$30,333
|
$20,323
|
Kochenderfer, James
|
CCR (NCI)
|
|
Alloreactive Regulatory T cells control GVHD and maintain GVL effect
|
5R01CA118116-05
|
$291,425
|
$291,425
|
YU, XUE-ZHONG
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Allosteric Inhibitor Discovery Technology for Protein Kinases
|
1R21CA169962-01
|
$165,844
|
$165,844
|
SMITHGALL, THOMAS
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Alternative RNA splicing and protein products in leukemia outcome (PQ11)
|
1R01CA170250-01
|
$594,337
|
$594,337
|
NESS, SCOTT
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
Amplifying Radiation Potency Against Leukemic Stem Cells
|
1R21CA164098-01
|
$211,410
|
$211,410
|
UCKUN, FATIH
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
Analysis of higher order chromatin structures in normal and cancer epigenomes
|
5R01CA140485-03
|
$333,111
|
$333,111
|
Kim, Tae Hoon
|
YALE UNIVERSITY
|
|
Analysis of the leukemic stem cell niche in chronic myeloid leukemia
|
5K08CA138916-03
|
$162,568
|
$162,568
|
Krause, Daniela
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Anatomic Pathology Residency Program
|
ZIEBC011384
|
$1,082,541
|
$54,127
|
Oberholtzer, John
|
CCR (NCI)
|
|
Animal models to study the role of INK4b loss in human acute myeloid leukemia
|
ZIABC011027
|
$687,814
|
$687,814
|
Wolff, Linda
|
CCR (NCI)
|
|
Antibody Engineering for Therapy and Diagnosis of Hematologic Malignancies
|
ZIABC010647
|
$297,122
|
$148,561
|
Rader, Christoph
|
CCR (NCI)
|
|
Antibody V Gene Expression B Cell Lymphocytic Leukemia
|
5R37CA049870-25
|
$318,906
|
$318,906
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
3R37CA044848-26S1
|
$77,500
|
$31,000
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Antitumor-Antibiotics from Marine Microorganisms
|
5R37CA044848-26
|
$373,010
|
$149,204
|
FENICAL, WILLIAM
|
UNIVERSITY OF CALIFORNIA AT SAN DIEGO
|
|
Apoptosis Induced by Glucocorticoids and MEK1/2 Inhibitors in Leukemia
|
5R01CA134473-04
|
$237,412
|
$237,412
|
HARADA, HISASHI
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Aptamer Based Technology for Molecular Analysis of Leukemia
|
5R01CA129311-05
|
$294,868
|
$294,868
|
Li, Ying
|
UNIVERSITY OF FLORIDA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S1
|
$75,000
|
$1,500
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-34S2
|
$143,846
|
$2,877
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-34
|
$3,953,813
|
$79,076
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arsenic Trioxide activated pathways in malignant cells
|
2R01CA121192-06
|
$266,285
|
$266,285
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Arsenic Trioxide and Acute Myeloid Leukemia
|
5R01CA093533-09
|
$247,445
|
$247,445
|
JING, YONGKUI
|
MOUNT SINAI SCHOOL OF MEDICINE
|
|
Assays for Screening Histone Modifications in Cancer
|
5R01CA107106-07
|
$226,740
|
$226,740
|
FREITAS, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,176,890
|
$35,307
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Augmenting Antitumor Immunity after Allografting
|
5R01CA122779-05
|
$295,461
|
$295,461
|
LUZNIK, LEO
|
JOHNS HOPKINS UNIVERSITY
|
Total relevant funding to Leukemia for this search: $234,716,347
|